Showing results (151-160 of 215) with videos related to

Sort By:
Pageof 22
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 25, 2023
Viewpoint: Antimicrobial Resistance Diagnostics Use Accelerator: Qualitative Research on Adherence to PrescriptionsAdélaïde Compaoré, Deborah Ekusai-Sebatta, David Kaawa-Mafigiri, et al.
Malaria Journal|July 12, 2013
Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patientsEva Maria Staehli Hodel, Monia Guidi, Boris Zanolari, et al.
Tropical Medicine & International Health : TM & IH|September 21, 2017
Seroepidemiological trend of strongyloidiasis in the Bolivian Chaco (1987-2013) in the absence of disease-specific control measuresMichele Spinicci, Fabio Macchioni, Antonia Mantella, et al.
Frontiers in Microbiology|October 26, 2019
Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis RelapseDinesh Mondal, Prakash Ghosh, Rajashree Chowdhury, et al.
One Health (Amsterdam, Netherlands)|June 23, 2021
Cross-sectional study on intestinal parasite infections in different ecological zones of the Department of La Paz, BoliviaJorge Aruni Chura, Fabio Macchioni, Federica Furzi, et al.
Influenza and Other Respiratory Viruses|February 24, 2023
Symptom-based case definitions for COVID-19: Time and geographical variations for detection at hospital admission among 260,000 patientsJoaquin Baruch, Amanda Rojek, Christiana Kartsonaki, et al.
Plos One|September 10, 2016
Experimental Treatment of Ebola Virus Disease with BrincidofovirJake Dunning, Stephen B Kennedy, Annick Antierens, et al.
Trials|July 5, 2024
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial-an update to the published protocolRindra Vatosoa Randremanana, Mihaja Raberahona, Mamy Jean de Dieu Randria, et al.
Trials|May 22, 2012
A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) projectCorinne S C Merle, Charalambos Sismanidis, Oumou Bah Sow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 25, 2023
Impact of Point-of-Care Rapid Diagnostic Tests on Antibiotic Prescription Among Patients Aged <18 Years in Primary Healthcare Settings in 2 Peri-Urban Districts in Ghana: Randomized Controlled Trial ResultsAlexander Adjei, Vida Kukula, Clement Tetteh Narh, et al.
Pageof 22